Uroplakin Peptide-Specific Autoimmunity Initiates Interstitial Cystitis/Painful Bladder Syndrome in Mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Izgi, Kenan ^a,b   Altuntas, Cengiz Z ^a,d   Bicer, Fuat ^a,b   Ozer, Ahmet ^a   Sakalar, Cagri ^c   Li, Xiaoxia ^c   Tuohy, Vincent K ^c   Daneshgari, Firouz ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d North American College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; UROPLAKIN 3; UROPLAKIN 3A[65-84];

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL AUTOIMMUNE CYSTITIS; FEMALE; GENE EXPRESSION; INTERSTITIAL CYSTITIS; LYMPH NODE CELL; LYMPHOCYTIC INFILTRATION; MEDICAL DEVICE; MICTURITION; MOUSE; NONHUMAN; PELVIS PAIN SYNDROME; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; T LYMPHOCYTE ACTIVATION; TH1 CELL; URINE VOLUME; VON FREY FILAMENT;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNITY; CELLS, CULTURED; CYSTITIS; CYSTITIS, INTERSTITIAL; DISEASE MODELS, ANIMAL; FEMALE; HYPERALGESIA; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; TH1 CELLS; URINARY BLADDER; URINATION; UROPLAKIN III;

EID: 84881600679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072067     Document Type: Article

References (57)

1. Moutzouris D-A, Falagas ME, (2009) Interstitial cystitis: an unsolved enigma. Clin J Am Soc Nephrol 4: 1844-1857.
2. Bogart LM, Berry SH, Clemens JQ, (2007) Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol 177: 450-456.
3. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187: 116-126.
4. Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, et al. (2011) Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol 186: 540-544.
5. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA (2005) Prevalence and incidence of interstitial cystitis in a managed care population. J Urol 173: 98-102; discussion 102.
6. Link CL, Pulliam SJ, Hanno PM, Hall SA, Eggers PW, et al. (2008) Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey. J Urol 180: 599-606.
7. Sand PK, (2006) Proposed pathogenesis of painful bladder syndrome/interstitial cystitis. J Reprod Med 51: 234-240.
8. van de Merwe JP, (2007) Interstitial cystitis and systemic autoimmune diseases. Nat Clin Pract Urol 4: 484-491.
9. Ochs RL, (1997) Autoantibodies and interstitial cystitis. Clin Lab Med 17: 571-579.
10. Keay S, Zhang CO, Trifillis AL, Hebel JR, Jacobs SC, et al. (1997) Urine autoantibodies in interstitial cystitis. J Urol 157: 1083-1087.
11. Lorenzo Gomez MF, Gomez Castro S, (2004) [Physiopathologic relationship between interstitial cystitis and rheumatic, autoimmune, and chronic inflammatory diseases]. Arch Esp Urol 57: 25-34.
12. Christmas TJ, (1994) Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol 73: 508-515.
13. MacDermott JP, Charpied GC, Tesluk H, Stone AR, (1991) Can histological assessment predict the outcome in interstitial cystitis? Br J Urol 67: 44-47.
14. Christmas TJ, Bottazzo GF, (1992) Abnormal urothelial HLA-DR expression in interstitial cystitis. Clin Exp Immunol 87: 450-454.
15. Westropp JL, Buffington CA, (2002) In vivo models of interstitial cystitis. J Urol 167: 694-702.
16. Birder LA, Hanna-Mitchell AT, Mayer E, Buffington CA, (2011) Cystitis, co-morbid disorders and associated epithelial dysfunction. Neurourol Urodyn 30: 668-672.
17. Altuntas CZ, Daneshgari F, Liu G, Fabiyi A, Kavran M, et al. (2008) Bladder dysfunction in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 203: 58-63.
18. Jane-wit D, Yu M, Edling AE, Kataoka S, Johnson JM, et al. (2002) A novel class II-binding motif selects peptides that mediate organ-specific autoimmune disease in SWXJ, SJL/J, and SWR/J mice. J Immunol 169: 6507-6514.
19. Altuntas CZ, Johnson JM, Tuohy VK, (2006) Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J Immunol 177: 1988-1996.
20. Solares CA, Edling AE, Johnson JM, Baek MJ, Hirose K, et al. (2004) Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides. J Clin Invest 113: 1210-1217.
21. Lin YH, Liu G, Kavran M, Altuntas CZ, Gasbarro G, et al. (2008) Lower urinary tract phenotype of experimental autoimmune cystitis in mouse: a potential animal model for interstitial cystitis. BJU Int 102: 1724-1730.
22. Altuntas CZ, Daneshgari F, Sakalar C, Goksoy E, Gulen MF, et al. (2012) Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis. Eur Urol 61: 193-200.
23. Phull H, Salkini M, Purves T, Funk J, Copeland D, et al. (2007) Angiotensin II plays a role in acute murine experimental autoimmune cystitis. BJU Int 100: 664-667.
24. Bullock AD, Becich MJ, Klutke CG, Ratliff TL, (1992) Experimental autoimmune cystitis: a potential murine model for ulcerative interstitial cystitis. J Urol 148: 1951-1956.
25. Lee G, (2011) Uroplakins in the lower urinary tract. Int Neuourol J 15: 4-12.
26. Kong XT, Deng FM, Hu P, Liang FX, Zhou G, et al. (2004) Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol 167: 1195-1204.
27. Snapper CM, McIntyre TM, Mandler R, Pecanha LM, Finkelman FD, et al. (1992) Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 175: 1367-1371.
28. Snapper CM, Paul WE, (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.
29. Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F, (2001) A new model of visceral pain and referred hyperalgesia in the mouse. Pain 92: 335-342.
30. Rudick CN, Schaeffer AJ, Thumbikat P, (2008) Experimental autoimmune prostatitis induces chronic pelvic pain. American journal of physiology Regulatory, integrative and comparative physiology 294: R1268-1275.
31. Westropp JL, Buffington CA, (2002) In vivo models of interstitial cystitis. J Urol 167: 694-702.
32. Bjorling DE, Wang ZY, Bushman W, (2011) Models of inflammation of the lower urinary tract. Neurourol Urodyn 30: 673-682.
33. Kato K, Kitada S, Longhurst PA, Wein AJ, Levin RM, (1990) Time-course of alterations of bladder function following acetone-induced cystitis. J Urol 144: 1272-1276.
34. Elgebaly SA, Allam ME, Walzak MP Jr, Oselinsky D, Gillies C, et al. (1992) Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation. J Urol 147: 1382-1387.
35. Sakata T, Smith RA, Garland EM, Cohen SM, (1989) Rat urinary bladder epithelial lesions induced by acrolein. J Environ Pathol Toxicol Oncol 9: 159-169.
36. McMahon SB, Abel C, (1987) A model for the study of visceral pain states: chronic inflammation of the chronic decerebrate rat urinary bladder by irritant chemicals. Pain 28: 109-127.
37. Oottamasathien S, Jia W, McCoard L, Slack S, Zhang J, et al. (2011) A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides. J Urol 186: 1684-1692.
38. Jerde TJ, Bjorling DE, Steinberg H, Warner T, Saban R, (2000) Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide. Urol Res 28: 269-273.
39. Lanteri-Minet M, Bon K, de Pommery J, Michiels JF, Menetrey D, (1995) Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 105: 220-232.
40. Vera PL, Iczkowski KA, Wang X, Meyer-Siegler KL, (2008) Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association. PLoS One 3: e3898.
41. Jasmin L, Janni G, Manz HJ, Rabkin SD, (1998) Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation. J Neurosci 18: 10016-10029.
42. Jasmin L, Janni G, Ohara PT, Rabkin SD, (2000) CNS induced neurogenic cystitis is associated with bladder mast cell degranulation in the rat. J Urol 164: 852-855.
43. Liu W, Evanoff DP, Chen X, Luo Y, (2007) Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response. J Immunol 178: 539-546.
44. Liu W, Deyoung BR, Chen X, Evanoff DP, Luo Y, (2008) RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model. J Autoimmun 30: 257-265.
45. Luber-Narod J, Austin-Ritchie T, Banner B, Hollins C 3rd, Maramag C, et al. (1996) Experimental autoimmune cystitis in the Lewis rat: a potential animal model for interstitial cystitis. Urol Res 24: 367-373.
46. Vera PL, Iczkowski KA, Howard DJ, Jiang L, Meyer-Siegler KL, (2010) Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice. Neurourol Urodyn 29: 1451-1457.
47. Doggweiler R, Jasmin L, Schmidt RA, (1998) Neurogenically mediated cystitis in rats: an animal model. J Urol 160: 1551-1556.
48. Buffington CA, (2004) Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol 172: 1242-1248.
49. Aboushwareb T, Zho G, Turner C, Andersson KE, Tar M, et al. (2007) Urodynamic characterization of mice lacking uroplakin II or III. FASEB J 21: A1308-A1308.
50. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL, (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.
51. Rudick CN, Bryce PJ, Guichelaar LA, Berry RE, Klumpp DJ, (2008) Mast cell-derived histamine mediates cystitis pain. PLoS One 3: e2096.
52. Rudick CN, Schaeffer AJ, Klumpp DJ, (2009) Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis. BMC Urol 9: 16.
53. Benvenga S, Santarpia L, Trimarchi F, Guarneri F, (2006) Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16: 225-236.
54. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S, (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
55. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408.
56. Liu G, Daneshgari F, (2006) Temporal diabetes- and diuresis-induced remodeling of the urinary bladder in the rat. Am J Physiol Regul Integr Comp Physiol 291: R837-843.
57. Mulder GB, Pritchett K, (2004) Rodent analgesiometry: the hot plate, tail flick and Von Frey hairs. Contemp Topics Lab Anim Sci 43: 54-55.